RDY 453 (Venlafaxine Extended Release 37.5 mg)

Pill with imprint RDY 453 is Gray & Pink, Capsule-shape and has been identified as Venlafaxine hydrochloride extended release 37.5 mg. It is supplied by Dr. Reddy's Laboratories Ltd..

Venlafaxine is used in the treatment of major depressive disorder; anxiety; depression; autism; anxiety and stress (and more), and belongs to the drug class serotonin-norepinephrine reuptake inhibitors. Risk cannot be ruled out during pregnancy. Venlafaxine 37.5 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for RDY 453

Venlafaxine hydrochloride extended release

Imprint:

RDY 453

Strength:

37.5 mg

Color:

Gray & Pink

Shape:

Capsule-shape

Availability:

Prescription only

Drug Class:

Serotonin-norepinephrine reuptake inhibitors

Pregnancy Category:

C - Risk cannot be ruled out

CSA Schedule:

Not a controlled drug

Labeler / Supplier:

Dr. Reddy's Laboratories Ltd.

Inactive Ingredients:

dimethylaminoethyl methacrylate - butyl methacrylate - methyl methacrylate copolymer
ethylcelluloses
gelatin
medium-chain triglycerides
microcrystalline cellulose
povidone
ferric oxide red
sodium stearyl fumarate
magnesium silicate
titanium dioxide
ferrosoferric oxide
ferric oxide yellow
potassium hydroxide
propylene glycol
shellac
ammonia
Note: Inactive ingredients may vary.

More Info Imprint SearchPrint

Get help with Imprint Code FAQs.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2018 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.